Thursday, March 8, 2018

503B Compounder Targeted By DOJ Fights Back, Says FDA Won't ...

Inside Health Policy-1 hour ago
The 503B compounding pharmacy that FDA and the Department of Justice are asking a federal judge to shut down is fighting back, using its bankruptcy to request a temporary restraining order that would halt any government action for 45 days. The company argues it has implemented the changes sought by FDA and that ...
Post a Comment